Barbara Gayle Duncan - Director at Atea Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AVIR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Barbara Gayle Duncan since 8/16/2023

Holdings reported by Barbara Gayle Duncan for Atea Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 33.2K $133K $4.00 Jun 16, 2024 Direct
Restricted Stock Units 29.6K $103K $3.49 Jun 21, 2024 Direct Common Stock
Stock Option (Right to Buy) 41.2K Jun 21, 2024 Direct Common Stock

Transactions reported by Barbara Gayle Duncan for Atea Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership